Screening  ||| S:0 E:10 ||| VBG
for  ||| S:10 E:14 ||| IN
haemorrhagic  ||| S:14 E:27 ||| JJ
disorders  ||| S:27 E:37 ||| NNS
in  ||| S:37 E:40 ||| IN
paediatric  ||| S:40 E:51 ||| JJ
patients  ||| S:51 E:60 ||| NNS
by  ||| S:60 E:63 ||| IN
means  ||| S:63 E:69 ||| NNS
of  ||| S:69 E:72 ||| IN
a  ||| S:72 E:74 ||| DT
questionnaire  ||| S:74 E:88 ||| NN
In  ||| S:88 E:91 ||| IN
children ||| S:91 E:99 ||| NNS
,  ||| S:99 E:101 ||| ,
screening  ||| S:101 E:111 ||| VBG
for  ||| S:111 E:115 ||| IN
haemorrhagic  ||| S:115 E:128 ||| JJ
disorders  ||| S:128 E:138 ||| NNS
is  ||| S:138 E:141 ||| VBZ
further  ||| S:141 E:149 ||| RB
complicated  ||| S:149 E:161 ||| VBN
by  ||| S:161 E:164 ||| IN
the  ||| S:164 E:168 ||| DT
fact  ||| S:168 E:173 ||| NN
that  ||| S:173 E:178 ||| IN
infants  ||| S:178 E:186 ||| NNS
and  ||| S:186 E:190 ||| CC
young  ||| S:190 E:196 ||| JJ
children  ||| S:196 E:205 ||| NNS
with  ||| S:205 E:210 ||| IN
mild  ||| S:210 E:215 ||| JJ
disease  ||| S:215 E:223 ||| NN
in  ||| S:223 E:226 ||| IN
many  ||| S:226 E:231 ||| JJ
cases  ||| S:231 E:237 ||| NNS
most  ||| S:237 E:242 ||| RBS
likely  ||| S:242 E:249 ||| RB
will  ||| S:249 E:254 ||| MD
not  ||| S:254 E:258 ||| RB
have  ||| S:258 E:263 ||| VB
a  ||| S:263 E:265 ||| DT
significant  ||| S:265 E:277 ||| JJ
history  ||| S:277 E:285 ||| NN
of  ||| S:285 E:288 ||| IN
easy  ||| S:288 E:293 ||| JJ
bruising  ||| S:293 E:302 ||| NN
or  ||| S:302 E:305 ||| CC
bleeding  ||| S:305 E:314 ||| VBG
making  ||| S:314 E:321 ||| VBG
the  ||| S:321 E:325 ||| DT
efficacy  ||| S:325 E:334 ||| NN
of  ||| S:334 E:337 ||| IN
a  ||| S:337 E:339 ||| DT
questionnaire  ||| S:339 E:353 ||| NN
even  ||| S:353 E:358 ||| RB
more  ||| S:358 E:363 ||| RBR
questionable ||| S:363 E:375 ||| JJ
.  ||| S:375 E:377 ||| .
We  ||| S:377 E:380 ||| PRP
compared  ||| S:380 E:389 ||| VBD
the  ||| S:389 E:393 ||| DT
questionnaires  ||| S:393 E:408 ||| NN
of  ||| S:408 E:411 ||| IN
a  ||| S:411 E:413 ||| DT
group  ||| S:413 E:419 ||| NN
of  ||| S:419 E:422 ||| IN
88  ||| S:422 E:425 ||| CD
children  ||| S:425 E:434 ||| NNS
in  ||| S:434 E:437 ||| IN
whom  ||| S:437 E:442 ||| WP
a  ||| S:442 E:444 ||| DT
haemorrhagic  ||| S:444 E:457 ||| JJ
disorder  ||| S:457 E:466 ||| NN
was  ||| S:466 E:470 ||| VBD
ruled  ||| S:470 E:476 ||| VBN
out  ||| S:476 E:480 ||| RP
by  ||| S:480 E:483 ||| IN
rigorous  ||| S:483 E:492 ||| JJ
laboratory  ||| S:492 E:503 ||| NN
investigation  ||| S:503 E:517 ||| NN
to  ||| S:517 E:520 ||| TO
a  ||| S:520 E:522 ||| DT
group  ||| S:522 E:528 ||| NN
of  ||| S:528 E:531 ||| IN
38  ||| S:531 E:534 ||| CD
children  ||| S:534 E:543 ||| NNS
with  ||| S:543 E:548 ||| IN
mild  ||| S:548 E:553 ||| JJ
von  ||| S:553 E:557 ||| NNP
Willebrand  ||| S:557 E:568 ||| NNP
disease  ||| S:568 E:576 ||| NN
( ||| S:576 E:577 ||| -LRB-
VWD ||| S:577 E:580 ||| NNP
) ||| S:580 E:581 ||| -RRB-
.  ||| S:581 E:583 ||| .
Questionnaires  ||| S:583 E:598 ||| NNP
about  ||| S:598 E:604 ||| IN
child ||| S:604 E:609 ||| NN
,  ||| S:609 E:611 ||| ,
mother  ||| S:611 E:618 ||| NN
and  ||| S:618 E:622 ||| CC
father  ||| S:622 E:629 ||| NN
were  ||| S:629 E:634 ||| VBD
obtained  ||| S:634 E:643 ||| VBN
prior  ||| S:643 E:649 ||| RB
to  ||| S:649 E:652 ||| TO
the  ||| S:652 E:656 ||| DT
laboratory  ||| S:656 E:667 ||| NN
diagnosis  ||| S:667 E:677 ||| NN
on  ||| S:677 E:680 ||| IN
the  ||| S:680 E:684 ||| DT
occasion  ||| S:684 E:693 ||| NN
of  ||| S:693 E:696 ||| IN
routine  ||| S:696 E:704 ||| JJ
preoperative  ||| S:704 E:717 ||| NN
screening.  ||| S:717 E:728 ||| CD
23 ||| S:728 E:730 ||| CD
/ ||| S:730 E:731 ||| CD
38  ||| S:731 E:734 ||| CD
children  ||| S:734 E:743 ||| NNS
with  ||| S:743 E:748 ||| IN
mild  ||| S:748 E:753 ||| JJ
VWD  ||| S:753 E:757 ||| NNP
showed  ||| S:757 E:764 ||| VBD
at  ||| S:764 E:767 ||| IN
least  ||| S:767 E:773 ||| JJS
one  ||| S:773 E:777 ||| CD
positive  ||| S:777 E:786 ||| JJ
question  ||| S:786 E:795 ||| NN
in  ||| S:795 E:798 ||| IN
the  ||| S:798 E:802 ||| DT
questionnaire ||| S:802 E:815 ||| NN
,  ||| S:815 E:817 ||| ,
while  ||| S:817 E:823 ||| IN
21 ||| S:823 E:825 ||| CD
/ ||| S:825 E:826 ||| CD
88  ||| S:826 E:829 ||| CD
without  ||| S:829 E:837 ||| IN
laboratory  ||| S:837 E:848 ||| NN
signs  ||| S:848 E:854 ||| NNS
showed  ||| S:854 E:861 ||| VBD
at  ||| S:861 E:864 ||| IN
least  ||| S:864 E:870 ||| JJS
one  ||| S:870 E:874 ||| CD
positive  ||| S:874 E:883 ||| JJ
question ||| S:883 E:891 ||| NN
.  ||| S:891 E:893 ||| .
There  ||| S:893 E:899 ||| EX
was  ||| S:899 E:903 ||| VBD
a  ||| S:903 E:905 ||| DT
trend  ||| S:905 E:911 ||| NN
to  ||| S:911 E:914 ||| TO
more  ||| S:914 E:919 ||| RBR
specific  ||| S:919 E:928 ||| JJ
symptoms  ||| S:928 E:937 ||| NNS
in  ||| S:937 E:940 ||| IN
older  ||| S:940 E:946 ||| JJR
children ||| S:946 E:954 ||| NNS
.  ||| S:954 E:956 ||| .
Three  ||| S:956 E:962 ||| CD
or  ||| S:962 E:965 ||| CC
more  ||| S:965 E:970 ||| RBR
positive  ||| S:970 E:979 ||| JJ
questions  ||| S:979 E:989 ||| NNS
were  ||| S:989 E:994 ||| VBD
found  ||| S:994 E:1000 ||| VBN
only  ||| S:1000 E:1005 ||| RB
in  ||| S:1005 E:1008 ||| IN
VWD  ||| S:1008 E:1012 ||| NNP
patients ||| S:1012 E:1020 ||| NNS
,  ||| S:1020 E:1022 ||| ,
but  ||| S:1022 E:1026 ||| CC
only  ||| S:1026 E:1031 ||| RB
in  ||| S:1031 E:1034 ||| IN
a  ||| S:1034 E:1036 ||| DT
few  ||| S:1036 E:1040 ||| JJ
of  ||| S:1040 E:1043 ||| IN
the  ||| S:1043 E:1047 ||| DT
control  ||| S:1047 E:1055 ||| NN
group ||| S:1055 E:1060 ||| NN
.  ||| S:1060 E:1062 ||| .
The  ||| S:1062 E:1066 ||| DT
question  ||| S:1066 E:1075 ||| NN
about  ||| S:1075 E:1081 ||| IN
menstrual  ||| S:1081 E:1091 ||| JJ
bleeding  ||| S:1091 E:1100 ||| NN
in  ||| S:1100 E:1103 ||| IN
mothers  ||| S:1103 E:1111 ||| NNS
did  ||| S:1111 E:1115 ||| VBD
not  ||| S:1115 E:1119 ||| RB
differ  ||| S:1119 E:1126 ||| VBP
significantly ||| S:1126 E:1139 ||| RB
.  ||| S:1139 E:1141 ||| .
Sensitivity  ||| S:1141 E:1153 ||| NN
of  ||| S:1153 E:1156 ||| IN
the  ||| S:1156 E:1160 ||| DT
questionnaire  ||| S:1160 E:1174 ||| NN
for  ||| S:1174 E:1178 ||| IN
a  ||| S:1178 E:1180 ||| DT
hemostatic  ||| S:1180 E:1191 ||| JJ
disorder  ||| S:1191 E:1200 ||| NN
was  ||| S:1200 E:1204 ||| VBD
0.60 ||| S:1204 E:1208 ||| CD
,  ||| S:1208 E:1210 ||| ,
while  ||| S:1210 E:1216 ||| IN
specifity  ||| S:1216 E:1226 ||| NN
was  ||| S:1226 E:1230 ||| VBD
0.76 ||| S:1230 E:1234 ||| CD
.  ||| S:1234 E:1236 ||| .
The  ||| S:1236 E:1240 ||| DT
negative  ||| S:1240 E:1249 ||| JJ
predictive  ||| S:1249 E:1260 ||| JJ
value  ||| S:1260 E:1266 ||| NN
was  ||| S:1266 E:1270 ||| VBD
0.82 ||| S:1270 E:1274 ||| CD
,  ||| S:1274 E:1276 ||| ,
but  ||| S:1276 E:1280 ||| CC
the  ||| S:1280 E:1284 ||| DT
positive  ||| S:1284 E:1293 ||| JJ
predictive  ||| S:1293 E:1304 ||| JJ
value  ||| S:1304 E:1310 ||| NN
was  ||| S:1310 E:1314 ||| VBD
only  ||| S:1314 E:1319 ||| RB
0.52 ||| S:1319 E:1323 ||| CD
.  ||| S:1323 E:1325 ||| .
Our  ||| S:1325 E:1329 ||| PRP$
small  ||| S:1329 E:1335 ||| JJ
study  ||| S:1335 E:1341 ||| NN
shows ||| S:1341 E:1346 ||| NNS
,  ||| S:1346 E:1348 ||| ,
that  ||| S:1348 E:1353 ||| IN
a  ||| S:1353 E:1355 ||| DT
questionnaire  ||| S:1355 E:1369 ||| NN
yields  ||| S:1369 E:1376 ||| NNS
good  ||| S:1376 E:1381 ||| JJ
results  ||| S:1381 E:1389 ||| NNS
to  ||| S:1389 E:1392 ||| TO
exclude  ||| S:1392 E:1400 ||| VB
a  ||| S:1400 E:1402 ||| DT
haemostatic  ||| S:1402 E:1414 ||| JJ
disorder ||| S:1414 E:1422 ||| NN
,  ||| S:1422 E:1424 ||| ,
but  ||| S:1424 E:1428 ||| CC
is  ||| S:1428 E:1431 ||| VBZ
not  ||| S:1431 E:1435 ||| RB
a  ||| S:1435 E:1437 ||| DT
sensitive  ||| S:1437 E:1447 ||| JJ
tool  ||| S:1447 E:1452 ||| NN
to  ||| S:1452 E:1455 ||| TO
identify  ||| S:1455 E:1464 ||| VB
such  ||| S:1464 E:1469 ||| PDT
a  ||| S:1469 E:1471 ||| DT
disorder ||| S:1471 E:1479 ||| NN
.  ||| S:1479 E:1481 ||| .
